Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M W Draper

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Hormone Research|January 1, 1991
Effects of human growth hormone on body composition in elderly menD Rudman, A G Feller, L Cohn, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 1, 1996
A controlled trial of raloxifene (LY139481) HCl: impact on bone turnover and serum lipid profile in healthy postmenopausal womenM W Draper, D E Flowers, W J Huster, et al.
American Journal of Obstetrics and Gynecology|January 10, 1998
Effects of raloxifene hydrochloride on the endometrium of postmenopausal womenS M Boss, W J Huster, J A Neild, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 29, 2000
Treatment of postmenopausal women with osteoporosis or low bone density with raloxifene. Raloxifene Study GroupP J Meunier, E Vignot, P Garnero, et al.
Annals of the New York Academy of Sciences|June 12, 1995
Raloxifene is a tissue-selective agonist/antagonist that functions through the estrogen receptorR Fuchs-Young, A L Glasebrook, L L Short, et al.
Archives of Internal Medicine|December 9, 2000
Long-term effects of raloxifene on bone mineral density, bone turnover, and serum lipid levels in early postmenopausal women: three-year data from 2 double-blind, randomized, placebo-controlled trialsC C Johnston, N H Bjarnason, F J Cohen, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Hormone Research|January 1, 1991
Effects of human growth hormone on body composition in elderly menD Rudman, A G Feller, L Cohn, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 1, 1996
A controlled trial of raloxifene (LY139481) HCl: impact on bone turnover and serum lipid profile in healthy postmenopausal womenM W Draper, D E Flowers, W J Huster, et al.
American Journal of Obstetrics and Gynecology|January 10, 1998
Effects of raloxifene hydrochloride on the endometrium of postmenopausal womenS M Boss, W J Huster, J A Neild, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 29, 2000
Treatment of postmenopausal women with osteoporosis or low bone density with raloxifene. Raloxifene Study GroupP J Meunier, E Vignot, P Garnero, et al.
Annals of the New York Academy of Sciences|June 12, 1995
Raloxifene is a tissue-selective agonist/antagonist that functions through the estrogen receptorR Fuchs-Young, A L Glasebrook, L L Short, et al.
Archives of Internal Medicine|December 9, 2000
Long-term effects of raloxifene on bone mineral density, bone turnover, and serum lipid levels in early postmenopausal women: three-year data from 2 double-blind, randomized, placebo-controlled trialsC C Johnston, N H Bjarnason, F J Cohen, et al.
Pageof 3